Education and Training
Perioperative Aminophylline to Improve Early Kidney Function After a Kidney Transplant
The aim of this study is to evaluate whether peri-transplant administration of a drug named aminophylline to children undergoing a kidney transplant from deceased donors improves early graft function and also projects on long term graft function.
Stanford is currently not accepting patients for this trial.
Stanford Investigator(s):
Intervention(s):
- drug: Aminophylline
- other: Theophylline drug levels
- drug: Placebo
Eligibility
Inclusion Criteria:
1. Pediatric kidney transplant recipients less than 21 years of age
2. Patients undergoing deceased donor (DD) kidney transplants
Exclusion Criteria:
1. Known history of non-sinus tachycardia
2. Multiple organ transplants recipients
3. Severe liver dysfunction
4. graft was placed on pump after harvesting
Ages Eligible for Study
1 Year - 21 Years
Genders Eligible for Study
All
Not currently accepting new patients for this trial
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Vivian Shih, MD
650-723-7903
Not Recruiting